United Therapeutics Corporation (UTHR)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	3,551,000	3,458,900	3,213,400	3,193,000	3,380,300	3,056,400	2,684,300	2,586,600	2,323,600	2,385,900	2,317,900	2,014,300	2,167,200	1,868,200	1,894,400	1,846,300	1,864,500	1,933,400	2,139,800	1,942,500
Total current liabilities	US$ in thousands	804,400	744,100	370,300	324,600	343,200	315,900	331,500	292,600	305,400	320,000	311,400	302,400	323,300	258,900	255,000	207,300	463,000	469,900	463,500	270,000
Current ratio		4.41	4.65	8.68	9.84	9.85	9.68	8.10	8.84	7.61	7.46	7.44	6.66	6.70	7.22	7.43	8.91	4.03	4.11	4.62	7.19

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,551,000K ÷ $804,400K
= 4.41

Based on the data provided, United Therapeutics Corp's current ratio has fluctuated over the past eight quarters. The current ratio, which measures the company's ability to cover its short-term liabilities with its current assets, reached its highest point in Q1 2023 at 9.84 and its lowest point in Q2 2022 at 8.10.

Overall, the company has maintained a consistently high current ratio above 4.0 for the past eight quarters, indicating a strong liquidity position. A current ratio above 1.0 suggests that the company has more current assets than current liabilities, which is typically viewed positively by investors and creditors.

The upward trend in the current ratio from Q1 2023 to Q2 2023, with a sharp increase from 4.65 to 8.68, may indicate an improvement in the company's short-term liquidity position during that period. However, the subsequent decrease in Q3 2023 to 4.65 raises questions about potential changes in the company's current asset and liability composition.

It is important for investors and analysts to further investigate the reasons behind these fluctuations in the current ratio to assess the company's ability to meet its short-term obligations and manage its liquidity effectively.